The Conygar Investment Company PLC (LON:CIC – Get Free Report)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 65.53 ($0.81) and traded as low as GBX 41.10 ($0.51). Conygar Investment shares last traded at GBX 41.10 ($0.51), with a volume of 32,785 shares.
Conygar Investment Stock Down 3.4 %
The company has a quick ratio of 11.14, a current ratio of 3.16 and a debt-to-equity ratio of 44.71. The firm has a market capitalization of £24.48 million, a PE ratio of -78.92 and a beta of 0.51. The business has a 50-day moving average price of GBX 50.63 and a 200-day moving average price of GBX 65.36.
Conygar Investment (LON:CIC – Get Free Report) last issued its earnings results on Tuesday, December 17th. The company reported GBX (56.46) (($0.70)) earnings per share (EPS) for the quarter.
Insider Buying and Selling
Conygar Investment Company Profile
The Conygar Investment Company PLC ("the Company") is incorporated in the United Kingdom and domiciled in England and Wales, is registered at Companies House under registration number 04907617, listed on the AIM market of the London Stock Exchange and limited by shares. The financial information set out in this report covers the six months to 31 March 2023, with comparative amounts shown for the six months to 31 March 2022 and the year to 30 September 2022, and includes the results and net assets of the Company and its subsidiaries, together referred to as the Group.
See Also
- Five stocks we like better than Conygar Investment
- Investing in Travel Stocks Benefits
- Oracle Announces Game-Changing News for the AI Industry
- Why Are These Companies Considered Blue Chips?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What is Forex and How Does it Work?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Conygar Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conygar Investment and related companies with MarketBeat.com's FREE daily email newsletter.